Clinical Trial Update: Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION-HF)

View source ↗

Summary

The EVOLUTION-HF real-world study evaluating dapagliflozin in Portuguese heart failure patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure | Status: COMPLETED